NOD2风险变异与失代偿期肝硬化中的病理性细菌易位 - Suppr | 超能文献

相似文献

1

NOD2 Risk Variants and Pathological Bacterial Translocation in Decompensated Cirrhosis.NOD2风险变异与失代偿期肝硬化中的病理性细菌易位

Dig Dis Sci. 2016 Jul;61(7):2142-4. doi: 10.1007/s10620-016-4151-0. Epub 2016 Apr 6.

2

Nucleotide-Binding Oligomerization Domain-Containing Protein 2 Variants in Patients with Spontaneous Bacterial Peritonitis.自发性细菌性腹膜炎患者中含核苷酸结合寡聚化结构域蛋白2变体

Dig Dis Sci. 2016 Jun;61(6):1545-52. doi: 10.1007/s10620-015-4024-y. Epub 2016 Jan 2.

3

The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial.印加试验（NOD2基因型指导的抗生素预防对肝硬化腹水患者生存的影响）：一项随机对照试验的研究方案

Trials. 2015 Mar 8;16:83. doi: 10.1186/s13063-015-0594-4.

4

Association of the NOD2 genotype with bacterial translocation via altered cell-cell contacts in Crohn's disease patients.NOD2 基因型与克罗恩病患者细胞间接触改变导致的细菌易位的关联。

Inflamm Bowel Dis. 2010 Aug;16(8):1311-21. doi: 10.1002/ibd.21223.

5

Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease.遗传易感性增加细菌易位会影响克罗恩病患者对生物治疗的反应。

Gut. 2014 Feb;63(2):272-80. doi: 10.1136/gutjnl-2012-303557. Epub 2013 Feb 1.

6

Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis.Toll 样受体（TLR）2 启动子和内含子 2 多态性与肝硬化自发性细菌性腹膜炎的风险增加相关。

J Hepatol. 2011 Nov;55(5):1010-6. doi: 10.1016/j.jhep.2011.02.022. Epub 2011 Feb 26.

7

Is bacterial DNA a better marker than endotoxin of bacterial translocation in decompensated cirrhosis?在失代偿期肝硬化中，细菌DNA作为细菌易位的标志物是否比内毒素更好？

Hepatology. 2011 Jun;53(6):2140-1; author reply 41-2. doi: 10.1002/hep.24303.

8

Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial.利福昔明对肝硬化患者的细菌组成、炎症和细菌易位影响较小：一项随机试验。

J Gastroenterol Hepatol. 2018 Jan;33(1):307-314. doi: 10.1111/jgh.13852.

9

[The INCA trial (impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver cirrhosis and ascites): precision medicine for patients with liver cirrhosis and ascites].

Z Gastroenterol. 2015 Nov;53(11):1350-2. doi: 10.1055/s-0041-103525. Epub 2015 Nov 12.

10

Changes in gut toll-like receptor-4 and nod-like receptor family pyrin domain containing-3 innate pathways in liver cirrhosis rats with bacterial translocation.肝硬化大鼠细菌易位时肠道 Toll 样受体 4 和 Nod 样受体家族 Pyrin 域包含 3 种先天途径的变化。

Clin Res Hepatol Gastroenterol. 2016 Nov;40(5):575-583. doi: 10.1016/j.clinre.2016.02.008. Epub 2016 Apr 6.

引用本文的文献

1

Genetic variants of innate immunity receptors are associated with mortality in cirrhotic patients with bacterial infection.先天性免疫受体的基因变异与肝硬化合并细菌感染患者的死亡率相关。

Liver Int. 2020 Mar;40(3):646-653. doi: 10.1111/liv.14392. Epub 2020 Feb 16.

本文引用的文献

1

The prognostic significance of bacterial DNA in patients with decompensated cirrhosis and suspected infection.细菌DNA在失代偿期肝硬化合并疑似感染患者中的预后意义

Liver Int. 2016 Aug;36(8):1133-42. doi: 10.1111/liv.13095. Epub 2016 Mar 23.

2

Nucleotide-Binding Oligomerization Domain-Containing Protein 2 Variants in Patients with Spontaneous Bacterial Peritonitis.自发性细菌性腹膜炎患者中含核苷酸结合寡聚化结构域蛋白2变体

Dig Dis Sci. 2016 Jun;61(6):1545-52. doi: 10.1007/s10620-015-4024-y. Epub 2016 Jan 2.

3

NOD2 gene variants are a risk factor for culture-positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis.